We are live on ! Find out more
WA

WestEnd Advisors Portfolio holdings

AUM $4.14B
1-Year Est. Return 15.99%
This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
+15.99%
3 Year Est. Return
+49.16%
5 Year Est. Return
+46.23%
10 Year Est. Return
+187.39%
AUM
$3.86B
AUM Growth
+$213M
Cap. Flow
-$25M
Cap. Flow %
-0.65%
Top 10 Hldgs %
68.67%
Holding
362
New
61
Increased
56
Reduced
87
Closed
8
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COST icon
76
Costco
COST
$418B
$2.93K ﹤0.01%
4
-3
-43% -$2.14K
USIG icon
77
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.4B
$2.84K ﹤0.01%
56
IYZ icon
78
iShares US Telecommunications ETF
IYZ
$1.19B
$2.77K ﹤0.01%
126
AVGO icon
79
Broadcom
AVGO
$1.79T
$2.65K ﹤0.01%
20
DIS icon
80
Walt Disney
DIS
$167B
$2.57K ﹤0.01%
21
+1
+5% +$104
AMGN icon
81
Amgen
AMGN
$198B
$2.56K ﹤0.01%
9
+1
+13% +$293
PFE icon
82
Pfizer
PFE
$143B
$2.55K ﹤0.01%
92
+6
+7% +$166
DHR icon
83
Danaher
DHR
$144B
$2.5K ﹤0.01%
10
ISRG icon
84
Intuitive Surgical
ISRG
$123B
$2.4K ﹤0.01%
6
+1
+20% +$378
HD icon
85
Home Depot
HD
$334B
$2.3K ﹤0.01%
6
ELV icon
86
Elevance Health
ELV
$83.2B
$2.07K ﹤0.01%
4
NEE icon
87
NextEra Energy
NEE
$185B
$2.04K ﹤0.01%
32
+3
+10% +$176
VZ icon
88
Verizon
VZ
$180B
$2.01K ﹤0.01%
48
+1
+2% +$40
KO icon
89
Coca-Cola
KO
$353B
$1.96K ﹤0.01%
32
-31
-49% -$1.86K
REGN icon
90
Regeneron Pharmaceuticals
REGN
$70.6B
$1.93K ﹤0.01%
2
CI icon
91
Cigna
CI
$75.3B
$1.82K ﹤0.01%
5
BMY icon
92
Bristol-Myers Squibb
BMY
$125B
$1.79K ﹤0.01%
33
+1
+3% +$51
SYK icon
93
Stryker
SYK
$122B
$1.79K ﹤0.01%
5
VRTX icon
94
Vertex Pharmaceuticals
VRTX
$124B
$1.67K ﹤0.01%
4
AMD icon
95
Advanced Micro Devices
AMD
$834B
$1.62K ﹤0.01%
9
CVS icon
96
CVS Health
CVS
$138B
$1.59K ﹤0.01%
20
BSX icon
97
Boston Scientific
BSX
$65.1B
$1.57K ﹤0.01%
23
+1
+5% +$64
ADBE icon
98
Adobe
ADBE
$91.1B
$1.51K ﹤0.01%
3
GILD icon
99
Gilead Sciences
GILD
$166B
$1.47K ﹤0.01%
20
+1
+5% +$77
T icon
100
AT&T
T
$150B
$1.44K ﹤0.01%
82
+2
+3% +$34

Similar funds

WestEnd Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, WestEnd Advisors held 362 positions worth $3.86B, up 5.9% from $3.65B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

WestEnd Advisors's Q1 2024 filing shows 61 new, 56 increased, 87 reduced and 8 closed positions. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 744,962 shares worth $57.6M. The largest sale was State Street Consumer Staples Select Sector SPDR ETF, an estimated $113M.

By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • WestEnd Advisors's largest Q1 2024 buy was Vanguard Short-Term Corporate Bond ETF: 744,962 shares worth $57.6M.
  • WestEnd Advisors added most to State Street Financial Select Sector SPDR ETF in Q1 2024, an estimated $134M increase.
  • WestEnd Advisors's biggest Q1 2024 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $113M.
  • WestEnd Advisors fully exited iShares Core Moderate Allocation ETF in Q1 2024, selling an estimated $491K.
  • WestEnd Advisors's ten largest holdings make up 69% of its $3.86B portfolio in Q1 2024.
  • WestEnd Advisors opened 61 new positions and closed 8 in Q1 2024.
  • WestEnd Advisors's portfolio value rose 5.9% quarter-over-quarter to $3.86B.

Based on WestEnd Advisors's 13F filing for Q1 2024, filed 7 May 2024.